|
Anagen effluvium
Potential causes of anagen effluvium overview
Anagen effluvium references
Anagen
effluvium
Anagen effluvium is a generalized diffuse hair loss from follicles
in the anagen growth phase with quite rapid development 1-4 weeks
after the initial trigger. Hair loss can be quite extensive as
it affects all follicles in an anagen stage of active growth and
around 90% of the average person's hair follicles are at this
stage at any one time. Anagen effluvium results from the simultaneous
inhibition of cell division in hair follicles leading to a sudden
stop in hair fiber production.
As with telogen
effluvium, anagen effluvium can be caused by a wide range
of triggers. Most significantly, some trigger factors may promote
anagen effluvium and telogen effluvium, even within the
same individual. This is a point worth noting when you read through
the summary list of trigger factors for anagen effluvium below.
Anagen effluvium can be induced by poisoning with arsenic or
thallium salts and other similar substances. Anagen effluvium
may be observed as part of a larger medical hair loss condition
such as alopecia
areata. However, extensive anagen effluvium is most often
seen in people undergoing chemotherapy as a cancer treatment.
The whole point of cancer treatment is to slow down or stop rapidly
dividing cells. This is good when trying to stop the development
of tumors but hair follicles are also regions of very rapidly
dividing cells. These cells produce the hair fiber and are some
of the fastest dividing cells in the body that are not cancerous.
Chemotherapy takes a shot gun approach by universally blocking
rapid cell division regardless of whether the cells are actually
cancerous or not.
Potential
causes of anagen effluvium overview
There are many potential causes of anagen effluvium. More common
causes are listed below and some are explained in greater detail
elsewhere.
- Genetic hereditary disease - Pollitt's syndrome, Marie
Unna type hypotrichosis
- Defective hormone production - Anagen effluvium may
be associated with hypopituitarism (hypopituitary dwarfism,
Simmond's disease, Sheehan's syndrome), thyroid gland defects
(hypothyroidism, hyperthyroidism), Cushing's syndrome, and occasionally
juvenile diabetes
- Nutrient deficiencies - Extreme deficiency of copper,
iron, zinc, biotin, essential fatty acids, or vitamin C in the
diet may lead to anagen effluvium
- Cancer treatments - Drug categories such as cytostatic
drugs, alkylating drugs, and antimetabolic drugs cause anagen
effluvium
- Ionizing radiation - X rays and gamma rays
- Toxic agents - Thallium, arsenic, lead, bismuth, vitamin
A and derivative drugs
Anagen
effluvium references
- Sommer M, Wilson C. Therapeutic approaches
to the management of common baldness. Int J Clin Pract. 1999
Jul-Aug;53(5):381-5.
- Tosi A, Misciali C, Piraccini BM, Peluso
AM, Bardazzi F. Drug-induced hair loss and hair growth. Incidence,
management and avoidance. Drug Saf. 1994 Apr;10(4):310-7.
- Peter RU, Braun-Falco O, Birioukov A,
Hacker N, Kerscher M, Peterseim U, Ruzicka T, Konz B, Plewig
G. Chronic cutaneous damage after accidental exposure to ionizing
radiation: the Chernobyl experience. J Am Acad Dermatol. 1994
May;30(5 Pt 1):719-23.
- Modan B, Alfandary E, Shapiro D, Lusky
A, Chetrit A, Shewach-Millet M, Movshovitz M. Factors affecting
the development of skin cancer after scalp irradiation. Radiat
Res. 1993 Jul;135(1):125-8.
- Schauer DA, Coursey BM, Dick CE, McLaughlin
WL, Puhl JM, Desrosiers MF, Jacobson AD. A radiation accident
at an industrial accelerator facility. Health Phys. 1993 Aug;65(2):131-40.
- Headington JT. Telogen effluvium. New
concepts and review. Arch Dermatol. 1993 Mar;129(3):356-63.
- Berth-Jones J, Shuttleworth D, Hutchinson
PE. A study of etretinate alopecia. Br J Dermatol. 1990 Jun;122(6):751-5.
- Gollnick H, Blume U, Orfanos CE. [Adverse
drug reactions on hair]. Z Hautkr. 1990 Dec;65(12):1128-34.
- Lancaster J. About radiotherapy--Part
II. Side effects and staff protection. Nurs RSA. 1989 Mar;4(3):41-3.
- Spencer LV, Callen JP. Hair loss in systemic
disease. Dermatol Clin. 1987 Jul;5(3):565-70.
- Messenger AG, Slater DN, Bleehen SS.
Alopecia areata: alterations in the hair growth cycle and correlation
with the follicular pathology. Br J Dermatol. 1986 Mar;114(3):337-47.
- Albert RE, Omran AR, Brauer EW, Cohen
NC, Schmidt H, Dove DC, Becker M, Baumring R, Baer RL. Follow-up
study of patients treated by x-ray epilation for tinea capitis.
II. Results of clinical and laboratory examinations. Arch Environ
Health. 1968 Dec;17(6):919-34.
|